Latest Distributions News

MPower Group has finalized the conversion of a $10 million project funding facility for its Narromine Renewable Energy Project into equity, with AMPYR Distributed Energy acquiring full ownership. The move strengthens MPower's balance sheet and supports its strategic push into hybrid renewable assets.

Oakridge International Limited reports a strong quarterly performance driven by increased contracted orders, strategic partnerships, and technological innovation, positioning the company for sustained growth into 2025.

Arcadia Minerals reports ongoing joint venture discussions across its Namibian projects and initiates a competitive bidding process for Swanson Tantalum Mine construction financing following a funding agreement termination.

Clarity Pharmaceuticals reports robust progress in its SECURE trial and secures FDA Fast Track Designation for its diagnostic agent 64Cu-SAR-bisPSMA, underpinning its growth and innovation in prostate cancer treatment.

8common Limited reports a record $1.2 million in SaaS revenue for Q2 FY25, driven by a 12% increase in users and strong government contract activity. Despite tight cash balances, the company remains funded through a chairman-backed facility.

Cokal Limited has strengthened its position in Central Kalimantan through strategic partnerships with PT Petrindo and Cratus Group, securing US$20 million in funding to boost coal production and infrastructure development.

Tissue Repair Limited reports initial patient enrolment in its pivotal Phase 3 trial for TR987®, alongside a robust 35% quarterly sales increase for its TR Pro+® product. The company is also advancing manufacturing and distribution strategies to support growth.

Vectus Biosystems reports completion of Phase Ib trials for its lead drug VB0004 and a robust cash position bolstered by a significant R&D tax refund, setting the stage for licensing discussions.

McLaren Minerals has secured critical tenement transfers and completed a heritage survey, setting the stage for drilling at its McLaren Titanium Project in Western Australia. The company is progressing steadily towards a pre-feasibility study expected in Q2 2025.

Aeris Environmental Ltd reported a 5% revenue increase to $766,000 in the December 2024 quarter, driven by strong margins and momentum in its AerisTech joint venture. The company’s expanding customer base and strategic partnerships signal promising growth in smart building solutions and consumables.

Nova Eye Medical reports a robust 39% increase in global sales driven by strong U.S. market demand and secures $6.6 million in fresh capital to fuel expansion and product development.

Visioneering Technologies reported a mixed Q4 FY'24 with a slight revenue decline but stronger cash flow and expanding global footprint, underpinned by promising clinical trial data.